Market Overview:
The global coronary chronic total occlusion (CTO) system market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of coronary artery diseases, technological advancements in CTO devices, and rising demand for minimally invasive procedures. Based on type, the global coronary CTO guidewires segment is projected to account for the largest share of the market in 2018. This segment is expected to grow at a CAGR of 7.8% from 2018 to 2030 due to the increasing demand for minimally invasive procedures and technological advancements in guidewires.
Product Definition:
The coronary chronic total occlusion (CTO) system is a device used to help physicians treat patients with coronary artery disease. The CTO system includes a guidewire and a catheter that are inserted into the patient's blood vessels. The guidewire is used to navigate through the blocked artery, and the catheter is then used to pull back the blockage.
Coronary CTO Guidewires:
Coronary CTO Guidewires, also known as coronary catheterization or coronary angiography guidance, is a minimally invasive procedure used to evaluate & treat heart diseases. This procedure involves the insertion of a guidewire through the blood vessels in order to view & treat blockages present in arteries and veins of the heart. The increasing prevalence rate of Coronary Heart Disease (CHD) across the globe is one of the major factors driving this market.
Coronary CTO Catheters:
The coronary CTO catheters are used in the Coronary Chronic Total Occlusion (CCTO) system. The CCTO is a procedure wherein, the patient’s artery is blocked with a stent and then inserted into the heart to treat heart attacks. This device also helps in reducing blood pressure levels and angina pain by opening up arteries that are constricted due to atherosclerosis or fatty deposits.
Application Insights:
The hospital application segment led the global coronary chronic total occlusion system market in 2017 and is projected to expand at a revenue-based CAGR of XX% over the forecast period. The coronarhythmic complications can be effectively treated with CTO devices, which help restore blood flow to the heart muscle by reducing blockage in arteries. This helps overcome critical shortfalls of oxygen supply to heart muscles, thereby improving patient¢â‚¬â„¢s chances for recovery and discharge from hospitalization.
In addition, technological advancements such as development of drug-eluting coatings for coronary chronic total occlusion systems are expected to drive their demand over the forecast period owing to properties such as reduction in inflammation and hardening of arteries that occur due these coatings after being exposed to blood cells for a longer duration resulting in improved outcomes for patients suffering from cardiac arrest or stroke caused due coronarhythmia during treatment with conventional medical therapies.
Regional Analysis:
North America dominated the global coronary chronic total occlusion system market in 2017. This can be attributed to favorable reimbursement policies, high patient awareness levels coupled with a well-developed healthcare infrastructure and relatively higher healthcare expenditure in this region. Moreover, increasing R&D activities by various companies for the development of advanced CTO systems is expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving economic conditions and growing patient disposable income resulting into an increase in health consciousness among individuals leading towards better diagnosis and treatment options for cardiovascular diseases such as CTOs. Furthermore, government initiatives encouraging private hospitals & clinics along with favorable insurance policies are some factors driving regional market growth during the estimated time frame.
Growth Factors:
- Increasing incidence of coronary artery diseases (CAD)
- Rising geriatric population susceptible to CAD
- Growing demand for minimally invasive procedures for the treatment of CAD
- Technological advancements in CTO devices and systems
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Coronary Chronic Total Occlusion System Market Research Report
By Type
Coronary CTO Guidewires, Coronary CTO Catheters, Coronary CTO Devices
By Application
Hospital, Clinic
By Companies
Boston Scientific, Abbott Laboratories, Medtronic, Philips, Terumo, Cardinal Health, Merit Medical Systems, Cook Medical, Asahi Intecc, Teleflex, Cardiovascular Systems Inc., Galt Medical, C.R. Bard, Angiodynamics, ACIST Medical Systems, Infraredx, Tryton Medical, B. Braun, Maquet
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
141
Number of Tables & Figures
99
Customization Available
Yes, the report can be customized as per your need.
Global Coronary Chronic Total Occlusion System Market Report Segments:
The global Coronary Chronic Total Occlusion System market is segmented on the basis of:
Types
Coronary CTO Guidewires, Coronary CTO Catheters, Coronary CTO Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Abbott Laboratories
- Medtronic
- Philips
- Terumo
- Cardinal Health
- Merit Medical Systems
- Cook Medical
- Asahi Intecc
- Teleflex
- Cardiovascular Systems Inc.
- Galt Medical
- C.R. Bard
- Angiodynamics
- ACIST Medical Systems
- Infraredx
- Tryton Medical
- B. Braun
- Maquet
Highlights of The Coronary Chronic Total Occlusion System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Coronary CTO Guidewires
- Coronary CTO Catheters
- Coronary CTO Devices
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Coronary Chronic Total Occlusion System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The coronary chronic total occlusion system is a group of medical conditions that affect the heart. These conditions include coronary artery disease, which is when the arteries that supply blood to the heart become blocked or narrowed. This can cause chest pain, shortness of breath, and even death if not treated.
Some of the major companies in the coronary chronic total occlusion system market are Boston Scientific, Abbott Laboratories, Medtronic, Philips, Terumo, Cardinal Health, Merit Medical Systems, Cook Medical, Asahi Intecc, Teleflex, Cardiovascular Systems Inc., Galt Medical, C.R. Bard, Angiodynamics, ACIST Medical Systems, Infraredx, Tryton Medical, B. Braun, Maquet.
The coronary chronic total occlusion system market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Coronary Chronic Total Occlusion System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Coronary Chronic Total Occlusion System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Coronary Chronic Total Occlusion System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Coronary Chronic Total Occlusion System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Coronary Chronic Total Occlusion System Market Size & Forecast, 2018-2028
4.5.1 Coronary Chronic Total Occlusion System Market Size and Y-o-Y Growth
4.5.2 Coronary Chronic Total Occlusion System Market Absolute $ Opportunity
Chapter 5 Global Coronary Chronic Total Occlusion System Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Coronary Chronic Total Occlusion System Market Size Forecast by Type
5.2.1 Coronary CTO Guidewires
5.2.2 Coronary CTO Catheters
5.2.3 Coronary CTO Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Coronary Chronic Total Occlusion System Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Coronary Chronic Total Occlusion System Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Coronary Chronic Total Occlusion System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Coronary Chronic Total Occlusion System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Coronary Chronic Total Occlusion System Analysis and Forecast
9.1 Introduction
9.2 North America Coronary Chronic Total Occlusion System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Coronary Chronic Total Occlusion System Market Size Forecast by Type
9.6.1 Coronary CTO Guidewires
9.6.2 Coronary CTO Catheters
9.6.3 Coronary CTO Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Coronary Chronic Total Occlusion System Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Coronary Chronic Total Occlusion System Analysis and Forecast
10.1 Introduction
10.2 Europe Coronary Chronic Total Occlusion System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Coronary Chronic Total Occlusion System Market Size Forecast by Type
10.6.1 Coronary CTO Guidewires
10.6.2 Coronary CTO Catheters
10.6.3 Coronary CTO Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Coronary Chronic Total Occlusion System Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Coronary Chronic Total Occlusion System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Coronary Chronic Total Occlusion System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Coronary Chronic Total Occlusion System Market Size Forecast by Type
11.6.1 Coronary CTO Guidewires
11.6.2 Coronary CTO Catheters
11.6.3 Coronary CTO Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Coronary Chronic Total Occlusion System Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Coronary Chronic Total Occlusion System Analysis and Forecast
12.1 Introduction
12.2 Latin America Coronary Chronic Total Occlusion System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Coronary Chronic Total Occlusion System Market Size Forecast by Type
12.6.1 Coronary CTO Guidewires
12.6.2 Coronary CTO Catheters
12.6.3 Coronary CTO Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Coronary Chronic Total Occlusion System Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Coronary Chronic Total Occlusion System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Coronary Chronic Total Occlusion System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Coronary Chronic Total Occlusion System Market Size Forecast by Type
13.6.1 Coronary CTO Guidewires
13.6.2 Coronary CTO Catheters
13.6.3 Coronary CTO Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Coronary Chronic Total Occlusion System Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Coronary Chronic Total Occlusion System Market: Competitive Dashboard
14.2 Global Coronary Chronic Total Occlusion System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific
14.3.2 Abbott Laboratories
14.3.3 Medtronic
14.3.4 Philips
14.3.5 Terumo
14.3.6 Cardinal Health
14.3.7 Merit Medical Systems
14.3.8 Cook Medical
14.3.9 Asahi Intecc
14.3.10 Teleflex
14.3.11 Cardiovascular Systems Inc.
14.3.12 Galt Medical
14.3.13 C.R. Bard
14.3.14 Angiodynamics
14.3.15 ACIST Medical Systems
14.3.16 Infraredx
14.3.17 Tryton Medical
14.3.18 B. Braun
14.3.19 Maquet
